MicRobiological diagnosis of invasive candidiasis
Abstract
background Candida spp. are responsible for opportunistic fungal infections in patients with known risk factors. Clinical diagnosis of invasive candidiasis is difficult because clinical features and symptoms are usually non-specific. The problem also represents isolation of pathogenic yeasts from sterile site which lacks desired level of sensitivity. conclusions Confirming diagnosis of invasive candidiasis requires isolation and identification of pathogenic fungi from a normally sterile site. Identification of Candida spp. is increasingly important for several reasons: Candida spp. differ in their susceptibility to antifungal agents, species-specific identification is relevant for epidemiological purposes and the severity of clinical manifestations differs depending on the infecting species. Serological tests can also be helpful for diagnosis of invasive candidiasis, among which direct detection of antigens is of most value. Newer techniques of molecular biology hold promise because of their high sensitivity and specificity, but are not yet standardized and clinically validatedDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.